RARα/RXR synergism potentiates retinoid responsiveness in cutaneous T-cell lymphoma cell lines-Reference-Cited by-同舟云学术

RARα/RXR synergism potentiates retinoid responsiveness in cutaneous T-cell lymphoma cell lines

Published:2017-07-03 Issue:11 Volume:26 Page:1004-1011
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Wang Lei¹,DeMarco Sebastian S.¹,Peaks Mary Stuart¹,Maiorana-Boutilier Abigail L.¹,Chen JianMing¹,Crouch Miranda J.¹,Shewchuk Brian M.¹,Shaikh Saame Raza¹,Phillips Charles M.²,Bridges Lance C.¹³^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology; The Brody School of Medicine; East Carolina University; Greenville NC USA

2. Department of Internal Medicine, Dermatology Division; The Brody School of Medicine; East Carolina University; Greenville NC USA

3. Biochemistry, Molecular and Cell Sciences; Arkansas College of Osteopathic Medicine; Arkansas Colleges of Health Education; Ft. Smith AR USA

Funder

Division of Research and Graduate studies

Brody School of Medicine

Arkansas Colleges of Health Education (LCB)

National Institutes of Health

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/exd.13348/fullpdf

Reference38 articles.

1. History of Retinoic Acid Receptors

2. A decade of molecular biology of retinoic acid receptors

3. Design of selective nuclear receptor modulators: RAR and RXR as a case study

4. Nuclear Hormone Receptors and Gene Expression

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Halogenated retinoid derivatives as dual RARα and RXRα modulators for treating acute promyelocytic leukemia cells;European Journal of Medicinal Chemistry;2024-11

2. Exploring the nexus of nuclear receptors in hematological malignancies;Cellular and Molecular Life Sciences;2024-02-09

3. Impact of VDR and RXR expression in non‐melanoma skin cancer pathogenesis;Experimental Dermatology;2022-04-10

4. The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer;Archives of Gynecology and Obstetrics;2021-12-06

5. Potential therapeutic uses of rexinoids;Advances in Immunopharmacology;2021